TABLE OF CONTENTS
1 Introduction
1.1 Market Definition
1.2 Market Scope
2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions & Exclusions
2.4 Secondary Data Sources
3 Market Overview
3.1 Report Segmentation & Scope
3.2 Value Chain Analysis: Wound Care Biologics Market
3.3 Key Market Trends
3.3.1 Drivers
3.3.2 Restraints
3.3.3 Opportunities
3.4 Porter’s Five Forces Analysis
3.4.1 Bargaining Power of Suppliers
3.4.2 Bargaining Power of Buyers
3.4.3 Threat of Substitution
3.4.4 Threat of New Entrants
3.4.5 Competitive Rivalry
3.5 Market Share Analysis
4 By Product Overview
4.1 Introduction
4.1.1 Market Size & Forecast (Value)
4.2 Biological Skin substitutes
4.3 Topical Agents
5. By Wound type
5.1 Introduction
5.1.1 Market Size & Forecast (Value)
5.2 Ulcers
5.3 Burns
5.4 Surgical and traumatic wounds
6 By End User
6.1 Introduction
6.1.1 Market Size & Forecast (Value)
6.2 Hospitals
6.3 Ambulatory surgical centers
6.4 Burn centers and wound clinics
7 Regional Overview
7.1 Introduction
7.1.1 Market Size & Forecast (Value)
7.2 America
7.2.1 North America
7.2.1.1 U.S.
7.2.1.1.1 By Product
7.2.1.1.2 By Wound Type
7.2.1.1.3 By End User
7.2.1.2 Canada
7.2.1.2.1 By Product
7.2.1.2.2 By Wound Type
7.2.1.2.3 By End User
7.2.1.3 Mexico
7.2.1.3.1 By Product
7.2.1.3.2 By Wound Type
7.2.1.3.3 By End User
7.2.2 Latin America
7.2.2.1 By Product
7.2.2.2 By Wound Type
7.2.2.3 By End User
7.3 Europe
7.3.1 Market Size & Forecast (Value)
7.3.2 Germany
7.3.2.1 By Product
7.2.2.2 By Wound Type
7.3.2.3 By End User
7.3.3 France
7.3.3.1 By Product
7.3.3.2 By Wound Type
7.3.3.3 By End User
7.3. 4 U.K.
7.3.4.1 By Product
7.3.4.2 By Wound Type
7.3.4.3 By End User
7.3.5 Italy
7.3.5.1 By Product
7.3.5.2 By Wound Type
7.3.5.3 By End User
7.3.6 Spain
7.3.6.1 By Product
7.3.6.2 By Wound Type
7.3.6.3 By End User
7.3.7 Rest of Europe
7.3.7.1 By Product
7.3.7.2 By Wound Type
7.3.7.3 By End User
7.4 Asia Pacific
7.4.1 Market Size & Forecast (Value)
7.4.2 Japan
7.4.2.1 By Product
7.4.2.2 By Wound Type
7.4.2.3 By End User
7.4.3 China
7.4.3.1 By Product
7.4.3.2 By Wound Type
7.4.3.3 By End User
7.4.4 Australia
7.4.4.1 By Product
7.4.4.2 By Wound Type
7.4.4.3 By End User
7.4.5 India
7.4.5.1 By Product
7.4.5.2 By Wound Type
7.4.5.3 By End User
7.4.6 South Korea
7.4.6.1 By Product
7.4.6.2 By Wound Type
7.4.6.3 By End User
7.4.8 Rest of Asia-Pacific
7.4.8.1 By Product
7.4.8.2 By Wound Type
7.4.8.3 By End User
7.5 Middle East & Africa
7.5.1 Market Size & Forecast (Value)
7.5.2 Saudi Arabia
7.5.2.1 By Product
7.5.2.2 By Wound Type
7.5.2.3 By End User
7.5.3 South Africa
7.5.3.1 By Product
7.5.3.2 By Wound Type
7.5.3.3 By End User
7.5.4 Kuwait
7.5.4.1 By Product
7.5.4.2 By Wound Type
7.5.4.3 By End User
7.5.5 Rest of Middle East & Africa
7.5.5.1 By Product
7.5.5.2 By Wound Type
7.5.5.3 By End User
8. Company Profile
8.1 Smith & Nephew
8.1.1 Company Overview
8.1.2 Financial Performance
8.1.3 Recent Developments
8.1.4 Product Portfolio
8.2 Molnlycke health care
8.2.1 Company Overview
8.2.2 Financial Performance
8.2.3 Recent Developments
8.2.4 Product Portfolio
8.3 Integra Lifesciences Corporation
8.3.1 Company Overview
8.3.2 Financial Performance
8.3.3 Recent Developments
8.3.4 Product Portfolio
8.4 Wright Medical
8.4.1 Company Overview
8.4.2 Financial Performance
8.4.3 Recent Developments
8.4.4 Product Portfolio
8.5 MiMedx Group
8.5.1 Company Overview
8.5.2 Financial Performance
8.5.3 Recent Developments
8.5.4 Product Portfolio
8.6 Anika Therapeutics
8.6.1 Company Overview
8.6.2 Financial Performance
8.6.3 Recent Developments
8.6.4 Product Portfolio
